Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ester-modified 99mTcO[SN(R)S/S] mixed ligand complexes: synthesis and preliminary evaluation.

C Tsoukalas1, I Pirmettis, G Patsis

  • 1Institute of Radioisotopes-Radiodiagnostic Products, National Center for Scientific Research Demokritos, 15310 Ag. Paraskevi, Athens, Greece.

Nuclear Medicine and Biology
|November 17, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

Chirality-controlled biomolecular recognition in Cu(I) metallodrugs: the first enantiomorphic CuP<sub>2</sub>O<sub>2</sub> systems with dual DNA/LOX activity.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Observation of Coherent ϕ(1020) Meson Photoproduction in Ultraperipheral PbPb Collisions at sqrt[s_{NN}]=5.36  TeV.

Physical review letters·2026
Same author

Search for New Physics in Jet Multiplicity Patterns of Multilepton Events at sqrt[s]=13  TeV.

Physical review letters·2025

Two novel technetium-99m (99mTc) complexes were synthesized for potential brain imaging applications. One complex remained stable, while the other hydrolyzed, indicating differential stability for radiopharmaceutical development.

Area of Science:

  • Radiochemistry
  • Nuclear Medicine
  • Medicinal Chemistry

Background:

  • Technetium-99m (99mTc) radiopharmaceuticals are crucial for diagnostic imaging.
  • Developing stable and targeted 99mTc complexes is essential for effective medical applications.
  • Esterase activity in vivo can affect the biodistribution and efficacy of radiotracers.

Purpose of the Study:

  • To synthesize and characterize novel 99mTc-(SNS/S) complexes with varying ester functionalities.
  • To evaluate the in vitro stability and in vivo tissue distribution of these new 99mTc complexes.
  • To explore their potential as brain-targeting radiopharmaceuticals.

Main Methods:

  • Synthesis of two novel 99mTc-(SNS/S) complexes (mono-ester 3 and diester 4) and their corresponding oxorhenium(V) analogues (1 and 2).

Related Experiment Videos

  • In vitro enzymatic hydrolysis assays to assess complex stability.
  • In vivo tissue distribution studies in mice to determine brain uptake and blood clearance.

    • Main Results:

    • Complex 3 (mono-ester) demonstrated stability upon enzymatic hydrolysis, while complex 4 (diester) was rapidly converted to a hydrophilic metabolite.
    • Both complexes 3 and 4 exhibited significant initial brain uptake.
    • Fast blood clearance was observed for both complexes 3 and 4.

    Conclusions:

    • The esterification pattern significantly influences the in vitro stability of 99mTc-(SNS/S) complexes.
    • Complex 3 shows promising characteristics for further development as a brain imaging agent due to its stability and initial brain uptake.
    • Further investigation is warranted to identify the hydrophilic metabolite of complex 4 and to optimize 99mTc complexes for targeted delivery.